Press Releases

Date Title View
Toggle Summary Second Sight Completes $4 million Private Placement of Common Stock with Gregg Williams, Chairman of the Board of Directors
LOS ANGELES --(BUSINESS WIRE)--Oct. 22, 2018-- Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind individuals, today
View HTML
Toggle Summary Second Sight Receives $1.6 Million Grant from National Institutes of Health to Support Orion Clinical Development
--Total Grant Amount Up to $6.3 Million Over Five Years-- LOS ANGELES --(BUSINESS WIRE)--Sep. 18, 2018-- Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an
View HTML
Toggle Summary Second Sight Appoints Pat Ryan Chief Operating Officer
SYLMAR, Calif. --(BUSINESS WIRE)--Sep. 4, 2018-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, announced
View HTML
Toggle Summary Second Sight to Present at Investor Conferences in September
LOS ANGELES --(BUSINESS WIRE)--Aug. 22, 2018-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, today
View HTML
Toggle Summary Second Sight Completes $5.0 million Private Placement of Common Stock with Gregg Williams, Chairman of the Board of Directors
LOS ANGELES --(BUSINESS WIRE)--Aug. 16, 2018-- Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, today
View HTML
Toggle Summary Second Sight Reports Second Quarter 2018 Financial Results
-- Achieves program milestones as Orion clinical and R&D activities advance -- -- Received FDA approval to enroll 6 th patient at Baylor -- LOS ANGELES --(BUSINESS WIRE)--Aug. 7, 2018-- Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight” or “the Company”), a developer, manufacturer
View HTML
Toggle Summary Second Sight to Discuss Second Quarter 2018 Financial Results on August 7, 2018 Conference Call
LOS ANGELES --(BUSINESS WIRE)--Jul. 31, 2018-- Second Sight Medical Products, Inc. (NASDAQ:EYES), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, will release its 2018 second quarter
View HTML
Toggle Summary Second Sight Medical Products, Inc. to Present at the 19th Annual B. Riley FBR Investor Conference
LOS ANGELES --(BUSINESS WIRE)--May 14, 2018-- Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, today
View HTML
Toggle Summary Second Sight Reports First Quarter 2018 Financial Results
--Orion Feasibility Study on Track with Encouraging Early Results and Four of Five Subjects Implanted -- -- Completed Private Placement of $10 million -- LOS ANGELES --(BUSINESS WIRE)--May 10, 2018-- Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight” or “the Company”), a developer,
View HTML
Toggle Summary Second Sight Completes $10 Million Private Placement of Common Stock with Gregg Williams, Chairman of the Board of Directors
LOS ANGELES --(BUSINESS WIRE)--May 7, 2018-- Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, today
View HTML